ArticleMethods in molecular biology (Clifton, N.J.)2026
Defining the Specificity of Blood-Group-Binding Lectins Through Microarray Analysis.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The assessment of blood group antigens is critical to transfusion medicine practice, as accurately identifying these antigens in both donors and patients is key to ensuring safe transfusions. Although plant lectins have long been used to aid in the identification of many carbohydrate-based blood group antigens, recent research has shown that a family of mammalian proteins known as galectins can also recognize and bind to blood group antigens. However, determining the fine specificity of lectins toward these antigens is challenging because of the structural complexity of the antigens and past limitations in the resources available to characterize their interactions in detail. To overcome this, the Consortium for Functional Glycomics (CFG) developed glycan microarrays composed of chemoenzymatically defined glycans, including a wide range of blood group antigens. This platform enables precise analysis of lectin-antigen interactions and uses additional glycans as controls to refine the specificity of these interactions. We will describe the use of this platform to characterize the specificity and relative affinity of lectins for blood group and related glycans.
Indexed as
Identifiers
42681437What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.